🇺🇸 FDA
Pipeline program

Botulinum Toxin A

DCI P05-71030

Approved small_molecule terminated

Quick answer

Botulinum Toxin A for Low Back Pain is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Low Back Pain
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials